Skip to main content
Equibles

FMR LLC

Position in PCRX — Pacira BioSciences, Inc.

CIK 315066 BOSTON, MA
Back to PCRX Full portfolio

Position in PCRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,505,314
+$3,392,644 QoQ
Shares Held
217,001
+132.1% QoQ
Ownership
0.544%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 254 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

FMR LLC holds $7,214,215,829 across 49 Drug Manufacturers - Specialty & Generic names. PCRX ranks #21 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 96,662,102 $1,534,994,177
2 ELAN
Elanco Animal Health Inc
 56,948,819 $1,401,510,433
3 HLN
Haleon plc
 120,991,250 $1,128,848,360
4 TEVA
Teva Pharmaceutical Industries Ltd
 30,258,016 $1,025,141,579
5 KNSA
Kiniksa Pharmaceuticals International, plc
 6,971,361 $445,818,534
6 LNTH
Lantheus Holdings, Inc.
 3,879,971 $430,443,982
7 AMLX
Amylyx Pharmaceuticals, Inc.
 16,727,909 $300,433,243
8 UTHR
UNITED THERAPEUTICS Corp
 473,409 $256,507,196

All Filings in PCRX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,505,314 217,001
2026-03-31 $2,112,670 93,481
2025-12-31 $1,912,428 73,896
2025-09-30 $2,624,003 101,824
2025-06-30 $2,215,051 92,680
2025-03-31 $3,632,075 146,160
2024-12-31 $1,495,349 79,371
2024-09-30 $1,010,832 67,165
2024-06-30 $1,230,400 43,006
2024-03-31 $1,231,417 42,143
2023-12-31 $1,842,608 54,612
2023-09-30 $1,698,812 55,372
2023-06-30 $1,958,340 48,873
2023-03-31 $2,033,724 49,834
2022-12-31 $1,858,492 48,135
2022-09-30 $2,618,223 49,224
2022-06-30 $2,841,716 48,743
2022-03-31 $3,524,762 46,184
2021-12-31 $20,698 344
2021-09-30 $3,696 66
2021-06-30 $3,762 62
2021-03-31 $4,415 63
2020-12-31 $3,351 56
2020-09-30 $8,325,597 138,483
2020-06-30 $2,938 56